Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy
- PMID: 21051975
- PMCID: PMC4361062
- DOI: 10.1111/IGC.0b013e3181f30c1b
Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy
Abstract
Objective: To evaluate the utility of preoperative magnetic resonance imaging (MRI) in determining whether primary disease site is cervical or endometrial in patients with inconclusive preoperative endometrial biopsy.
Methods: We retrospectively identified all patients who underwent pelvic MRI and who had a preoperative diagnosis of cervical or endometrial cancer at MD Anderson Cancer Center between 1990 and 2006. The subset in which endometrial biopsy did not clarify the primary disease site was analyzed. Magnetic resonance imaging results were compared with postoperative histopathologic findings.
Results: A total of 168 patients who underwent MRI who had a preoperative diagnosis of cervical or endometrial cancer were identified. Of these patients, 51 had an inconclusive endometrial biopsy. Magnetic resonance imaging suggested an endometrial primary tumor without cervical invasion in 28 patients, of whom 21 (75%) actually had such a tumor and 7 had an endometrial primary tumor with cervical invasion. Magnetic resonance imaging suggested an endometrial primary tumor with cervical invasion in 3 patients, all of whom had such a tumor. Magnetic resonance imaging suggested a cervical primary tumor in 6 patients, of whom 5 had such a tumor and 1 had an endometrial primary tumor without cervical invasion. Magnetic resonance imaging was inconclusive (did not clarify primary disease site or no lesion visualized) in 14 (27%) of 51 patients, 6 of whom had an endocervical primary tumor or an endometrial tumor with cervical involvement. Overall, preoperative MRI was either inaccurate or unhelpful in 22 (43%) of 51 patients.
Conclusion: Preoperative MRI in patients with inconclusive endometrial biopsy is inaccurate or unhelpful in nearly half of patients.
Conflict of interest statement
Conflict of Interest Statement: The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI).Eur J Gynaecol Oncol. 2003;24(6):517-22. Eur J Gynaecol Oncol. 2003. PMID: 14658593
-
Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas.Acta Obstet Gynecol Scand. 2015 Jan;94(1):95-101. doi: 10.1111/aogs.12523. Epub 2014 Nov 11. Acta Obstet Gynecol Scand. 2015. PMID: 25287060
-
MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive.Clin Radiol. 2013 Nov;68(11):1107-13. doi: 10.1016/j.crad.2013.05.095. Epub 2013 Jul 10. Clin Radiol. 2013. PMID: 23849621
-
Preoperative risk stratification of early-stage endometrial cancer assessed by multimodal magnetic resonance functional imaging.Magn Reson Imaging. 2025 Apr;117:110283. doi: 10.1016/j.mri.2024.110283. Epub 2024 Nov 28. Magn Reson Imaging. 2025. PMID: 39615611 Review.
-
Staging endometrial cancer: role of magnetic resonance imaging.J Magn Reson Imaging. 2001 Jun;13(6):850-5. doi: 10.1002/jmri.1121. J Magn Reson Imaging. 2001. PMID: 11382943 Review.
Cited by
-
Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix.Abdom Radiol (NY). 2021 Feb;46(2):732-744. doi: 10.1007/s00261-020-02586-4. Abdom Radiol (NY). 2021. PMID: 32671441
-
Role of MRI in diagnosing the primary site of origin in indeterminate cases of uterocervical carcinomas: a systematic review and meta-analysis.Br J Radiol. 2022 Jan 1;95(1129):20210428. doi: 10.1259/bjr.20210428. Epub 2021 Oct 28. Br J Radiol. 2022. PMID: 34623892 Free PMC article.
-
Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial.Pilot Feasibility Stud. 2018 Jan 4;4:27. doi: 10.1186/s40814-017-0218-8. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 29318031 Free PMC article.
References
-
- Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol. 1980;136:679–88. - PubMed
-
- Yura Y, Tauchi K, Koshiyama M, et al. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. Gynecol Oncol. 1996;63:114–9. - PubMed
-
- Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51. - PubMed
-
- Staebler A, Sherman ME, Zaino RJ, Ronnett BM. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol. 2002;26:998–1006. - PubMed
-
- Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr. 1995;19:766–72. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical